Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. The goal is to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network (BPN) or other translational programs. Key aspects of this opportunity include: * Developing in vitro and/or ex vivo assays * Conducting iterative screening efforts to identify potential therapeutic agents * Characterizing therapeutic agents for neurological or neuromuscular disorders * Advancing projects for the Blueprint Neurotherapeutics Network (BPN) or other translational programs * Eligibility is open to various institutions, including public and state-controlled institutions of higher education, non-profits, and for-profit organizations.